Vasculitis cutáneas
Resumen
Las vasculitis cutáneas comprenden un amplio espectro de síndromes clínicos, que usualmente se presentan como púrpura palpable, caracterizados por inflamación perivascular segmentaria y necrosis fibrinoide de la pared de los vasos sanguíneos. La piel es a menudo el único órgano comprometido, pero puede ocurrir compromiso sistémico.
Este artículo describe la etiología, clasificación, diagnóstico y tratamiento de las vasculitis sistémicas y cutáneas.
Biografía del autor/a
Luz Adriana Vásquez O., Universidad Pontificia Bolivariana
R II Dermatología, Universidad Pontificia Bolivariana, Medellín.
Referencias bibliográficas
https://doi.org/10.1016/1040-0486(93)90018-Q
2. Ryan TJ. Cutaneous Vasculitis. En: Rook A, Wilkinson DS, Ebling FJG (eds). Textbook of Dermatology. Oxford, Blackwell Scientific Publications 1998; 2155-2225.
3. Sneller M, Fauci A. Pathogenesis of vasculitis Syndromes. Med Clin NA 1997; 81:221-259.
https://doi.org/10.1016/S0025-7125(05)70512-5
4. Soter N. Cutaneous necrotizing venulitis. En: Fitzpatrick Thomas, Freedberg lrwin, Eisen Arthur et al (eds). Dermatology in General Medicine. 5a. ed. 1999; 2044-2058.
5. Comacchi C, Ghersetich l. Cutaneous Necrotizing Vasculitis. lnt J Dermatol 1996: 35:457-474.
https://doi.org/10.1111/j.1365-4362.1996.tb01656.x
6. Gocke DJ, Hsu K, Morgan C et al. Association between polyarteritis and Australian p. antigen. Lancet 1970; 2:1149.
https://doi.org/10.1016/S0140-6736(70)90339-9
7. Lotti T, Ghersetich 1, Jorizzo Jet al. Cutaneous small vessel vasculitis: J Am Acad Dermatol 1998; 39:667-687.
https://doi.org/10.1016/S0190-9622(98)70039-8
8. Rao J, Allen N, Pincus T. Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis. Ann lntern Med 1998; 129:345-352.
https://doi.org/10.7326/0003-4819-129-5-199809010-00001
9. Jennette JC, Falk RJ. Small Vessel Vasculitis. N Eng J Med 1997; 337:1512-1523.
https://doi.org/10.1056/NEJM199711203372106
10. Carrascosa JM. Vasculitis necrosantes cutáneas: Consideraciones conceptuales y patogénicas. Piel 1998; 13:163-169.
11. Lhote F, Guillevin L. Polyarteritis nodosa, Microscopic polyangiitis and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum Dis Clin NA 1995; 21:911- 947.
12. Gross WL. Antineutrophil cytoplasmic autoantibody tes ting in vasculitides. Rheum Dis Clin NA 1995; 21:987- 1011.
13. Brasile L, Kremer JM, Clarke JL et al. ldentification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med 1989; 87:74.
https://doi.org/10.1016/S0002-9343(89)80486-3
14. Specks U, Wheatley CL, McDonald T J, et al. Anticyto plasmic autoantibodies: T heir immunodiagnostic value in Wegener's granulomatosis. Mayo Clin Proc 1989; 64:28.
https://doi.org/10.1016/S0025-6196(12)65300-2
15. Van der Woude FJ, Lobatto S, Permin H et al: Autoanti bodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:425.
https://doi.org/10.1016/S0140-6736(85)91147-X
16. Jennette J, Ewert B, Falk R: Do antineutrophil cytoplas mic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis? Rheum Dis Clin North Am 1993; 19:1.
17. Lie JT. Diagnostic Histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Dis Clin North Am 1990, 16:269.
18. Barnhill R, Busam K. Vascular diseases: Lever's Histo pathology of the Skin. Elenitsas R, Jaworsky C, Johnson B (eds), 8a. ed. Philadelphia 1997; 185-208.
19. Zax R, Hodge S, Callen J. Cutaneous Leucocytoclastic Vasculitis. Arch Dermatol 1990; 126:69-72.
https://doi.org/10.1001/archderm.1990.01670250075012
20. Chen KR, Pittelkow MR, Conn DL et al. Eosinophilic vasculitis in connective disease. J Am Acad Dermatol 1996; 35:173-182.
https://doi.org/10.1016/S0190-9622(96)90318-7
21. Jennette CJ, Milling DM, Falk RJ. Vasculitis affecting the skin. A Review. Arch Dermatol 1994; 130:899-906.
https://doi.org/10.1001/archderm.1994.01690070093015
22. Gibson L, Daniel Su WP. Cutaneous Vasculitis. Rheum Dis Clin North Am. 1995; 21:1097-1113.
23. Veien N, Krogdahl A. Cutaneous Vasculitis induced by food additives. Acta Derm Venereol 1991; 71:73-74.
24. Millikan LE, Flynn T C. lnfectious etiologies of cutaneous vasculitis. Clin Dermatol 1999; 17:509-514.
https://doi.org/10.1016/S0738-081X(99)00061-9
25. Daoud MS, El Azhary RA, Gibson LE et al. Chronic hepatitis C, cryoglobulinemia and cutaneous necrotizing vasculitis. J Am Acad Dermatol 1996; 34:219-223.
https://doi.org/10.1016/S0190-9622(96)80115-0
26. Bonnefoy M, Claudy AL. Etude prospective de facteurs associes aux vascularites leucocytoclasiques. Ann Dermatol Venereol 1988; 115:27-32.
27. Popp J, Harrist T, Dienstag J et al Cutaneous vasculitis associated with acute and chronic hepatitis. Arch lntern Med 1981; 141:623-629.
https://doi.org/10.1001/archinte.1981.00340050075018
28. Chakravarty K, Merry P. Systemic vasculitis and atypical infections: Report of two cases. Postgrad Med J 1999; 75:544-546.
https://doi.org/10.1136/pgmj.75.887.544
29. Finkel TH, Ti:irok T J, Ferguson PJ et al: Chronic parvo virus 819 infection and systemic necrotizing vasculitis. Oportunistic infection or aetiological agent? Lancet 1994; 343:1255.
https://doi.org/10.1016/S0140-6736(94)92152-0
30. Bacon P, Carruthers D. Vasculitis associated with connective tissue disorders. Rheum Dis Clin North Am 1995; 21:1077-1096.
31. Kurzrock R, Cohen P. Vasculitis and Cancer. Clin Dermatol 1993; 11:175-187.
https://doi.org/10.1016/0738-081X(93)90115-S
32. Mertz L, Conn D. Vasculitis associated with malignancy.
Current opinion in Rheumatology 1992; 4:39-46.
33. Guillevin L, Amouroux J, Arbeille B et al. Churg-Strauss angiitis. Arguments favoring the responsibility of inhaled antigens. Chest 1991; 100:1472.
https://doi.org/10.1378/chest.100.5.1472
34. Duna G, Galperin C, Hoffman G. Wegener granuloma tosis. Rheum Dis Clin North Am, 1995; 21:949-986.
35. Hu CH, O'Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener's granulomatosis. Arch Dermatol 1977; 113:175.
https://doi.org/10.1001/archderm.1977.01640020047008
36. Mangold MC, Callen JP. Cutaneous leucocytoclastic vasculitis associated with active Wegener's granulo matosis. J Am Acad Dermatol 1992; 26:579.
https://doi.org/10.1016/0190-9622(92)70084-S
37. Francés C, Piette JC, Saada V et al. Wegener's Granulomatosis. Dermatological Manifestations in 75 cases with Clinicopathological Correlation. Arch Dermatol 1994; 130:861-867.
https://doi.org/10.1001/archderm.1994.01690070055008
38. Mehregan D, Hall M, Gibson L. Urticaria! vaculitis: A histopathological and clinical review of 72 cases. J Am Acad Dermatol 1992; 26:441-448.
https://doi.org/10.1016/0190-9622(92)70069-R
39. Mehregan D. Pathophysiology of urticaria! vasculitis.
Arch Dermatol 1998; 134:88-89.
https://doi.org/10.1001/archderm.134.1.88
40. Prins M, Veraart JM, Vermeulen AH et al. Leucocyto clastic vasculitis induced by prolonged exercise. Br J Dermatol 1996; 134:915-918.
https://doi.org/10.1111/j.1365-2133.1996.tb06325.x
41. Kano Y, Orthara M, Shiohara T. Cellular and molecular dynamics in exercise-induced urticaria! vasculitis lesions. Arch Dermatol 1998; 134:62-67.
https://doi.org/10.1001/archderm.134.1.62
42. Nishijima C, Hatta N, lnaoki M et al. Urticaria! vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia. Eur J Dermatol 1999; 9: 54-56.
43. Davis M, Daoud M, Kirby B et al. Clinicopathologic corre- lation of hypocomplementemic and normocomplementemic urticaria! vasculitis. J Am Acad Dermatol.1998; 38: 899-905.
44. Zeiss R, Burch F, Marder R et al. A hypocomplementemic vasculitic urticaria! syndrome. Am J Medicine 1988; 68: 867-875.
https://doi.org/10.1016/0002-9343(80)90216-8
45. Millns J, Randle H, Solley G et al. The therapeutic res- ponse of urticaria! vasculitis to indomethacin. J Am Acad Derm; 1980; 3:349-355.
https://doi.org/10.1016/S0190-9622(80)80327-6
46. Dillon M, Ansell B. Vasculitis in children and adolescents. Rheum Dis Clin North Am. 1995; 21:1115-1136.
47. Raimer S, Sánchez R. Vasculitis in children. Seminars in Dermatol 1992; 11:48-56.
48. Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD et al. Schönlein Henoch Purpura in adult patients. Pre- dictive factors for lgA glomerulonephritis in a retrospec- tive study of 57 cases. Arch Dermatol 1997; 133:438- 442.
https://doi.org/10.1001/archderm.1997.03890400034005
49. Levinsky RJ, Baratt TM. lgA immune complexes in Henoch-Schönlein purpura. Lance! 1979; 2:1100
https://doi.org/10.1016/S0140-6736(79)92505-4
50. Heng MCY. Henoch Schönlein purpura. Br J Dermatol 1974; 109:664.
51. Stephansson EA, Scheynius A. lmmunological studies of cutaneous vasculitis and primary antiphospholipid syndrome. Eur J Dermatol 1993; 3:289.
52. Wilkinson SM, English JS, Smith NP et al. Erythema elevatumdiutinum: A clinicopathological study. ClinExp Dermatol 1992; 17:87-93. Farella V, Lotti T, Difonzo E et al. Erythema Elevatum Diutinum. lnt J Dermatol 1994; 33:638-640.
https://doi.org/10.1111/j.1365-2230.1992.tb00171.x
54. Margolis D. Dermatology of the lower extremities: three unusual diseases that cause ulcers. Wounds1993;283: 7-11.
55. Kirsner RS, Pardes JB, Eaglstein WH et al. The clinical spectrum of lipo dermatoesclerosis. JAmAcadDermatol 1990; 126:1195-1197.
56. Agnello V, Knight G, Abel G. lnterferón a-2 for cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 331:751.
https://doi.org/10.1056/NEJM199408113310613
57. Gorevic P, Kassab H, Levo Y, et al: Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980; 69:287.
https://doi.org/10.1016/0002-9343(80)90390-3
58. Parsons M, Russo GG, Millikan LE. Dermatologic disorders associated with viral hepatitis infections. lnt J Dermatol 1996; 35:77-81.
https://doi.org/10.1111/j.1365-4362.1996.tb03265.x
59. Misiani R, Bellavita P, Fenili D et al. lnterferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330:751-756.
https://doi.org/10.1056/NEJM199403173301104
60. Madi N, Steiger G, Estreicher J et al. Detective immune adherence and elimination of hepatitis B surface anti- gen/antibody complexes in patients with mixed essential cryoglobulinemia type 11. J lmmunol 1991; 147: 495- 502.
61. AgnelloV. lnterferon alfa-2a for cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 331: 400.
https://doi.org/10.1056/NEJM199408113310613
62. lrvine A, Bruce 1, Walsh M et al. Microscopic polyangiitis. Arch Dermatol 1997; 133:474-477.
https://doi.org/10.1001/archderm.1997.03890400074010
63. Lockwood CM, Thiru S, lsaacs JD et al. Long-term remi- ssion of intractable systemic vasculitis with monoclonal antibody therapy. Lance! 1993; 341:1620.
https://doi.org/10.1016/0140-6736(93)90759-A
64. Molreland LW, Ball GV. Cutaneous polyarteritis nodosa. Am J Med. 1990; 88:426.
https://doi.org/10.1016/0002-9343(90)90502-5
65. Cohen W, Kallenberg C: Neurologic manifestations of systemis vasculitides. Rheum Dis Clin North Am 1993, 19: 913.
66. Conn DL. Polyarteritis. Rheum Dis Clin North Am; 1990; 16:341.
67. Suzuki A, Tizard EJ, Gooch V et al. Kawasaki disease: echocardiographic features in 91 cases presenting in the United Kingdom. Arch Dis Child 1990; 90:1142.
https://doi.org/10.1136/adc.65.10.1142
68. Allen N, Bressler P. Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes. Med Clin NA 1997; 81:243-259.
https://doi.org/10.1016/S0025-7125(05)70513-7
69. Mandell BF, Hoffman G. Differentiating the vasculitides. Rheum Dis Clin North Am 1994; 20: 409-441.
70. Sais G, Villader A, Jucgla A. Prognostic factors in leucocytoclastic vasculitis. Arch Dermatol 1998; 134: 309-315.
https://doi.org/10.1001/archderm.134.3.309
71. Callen J, Louisville KY: Colchicine is effective in controlling chronic cutaneous leucocytoclastic vasculitis. J Am Acad Dermatol 1985; 13:193-200.
https://doi.org/10.1016/S0190-9622(85)70158-2
72. Houck H, Kauffman L, Casey D. Minocycline treatment for Leucocytoclastic Vasculitis associated with Rheumatoid Arthritis. Arch Dermatol1997;33:15-16.
https://doi.org/10.1001/archderm.133.1.15
73. Mathieson PW, Cobbold SP, Hale CG et al. Monoclonal antibody therapy in systemic vasculitis. N Engl J Med. 1990; 323:250-254.
https://doi.org/10.1056/NEJM199007263230407